Last reviewed · How we verify
Golytely
At a glance
| Generic name | Golytely |
|---|---|
| Also known as | polyethylene glycol 3350 and electrolytes oral solution, Bowel purge |
| Sponsor | Yale University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy (PHASE4)
- Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease (NA)
- Colonoscopy Bowel Prep Comparison Among Diabetic Patients (PHASE4)
- Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial (PHASE4)
- Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen (PHASE4)
- The Study on the Effect of Different Administration Methods of Simethicone in Reducing Bubbles During Bowel Preparation (PHASE4)
- Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens (PHASE4)
- Improving Outpatient Colonoscopy Bowel Prep with the Orton Score (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Golytely CI brief — competitive landscape report
- Golytely updates RSS · CI watch RSS
- Yale University portfolio CI